Advertisement
Screener

PALATIN TECHNOLOGIES, INC. (PTN) Increase (Decrease) in Other Current Liabilities

2.8 / 5 stars · 68/120 Roast Me

PALATIN TECHNOLOGIES, INC. Increase (Decrease) in Other Current Liabilities

PALATIN TECHNOLOGIES, INC. (PTN) reported Increase (Decrease) in Other Current Liabilities of $141.40 thousand for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-23.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2025-09-23

  • PALATIN TECHNOLOGIES, INC. increase (decrease) in other current liabilities for the quarter ending 2025-06-30 was $141.40K.
  • PALATIN TECHNOLOGIES, INC. increase (decrease) in other current liabilities for the quarter ending 2025-03-31 was $0.00.
  • PALATIN TECHNOLOGIES, INC. increase (decrease) in other current liabilities for the quarter ending 2024-06-30 was -$1.34M.
  • PALATIN TECHNOLOGIES, INC. increase (decrease) in other current liabilities for the quarter ending 2024-03-31 was -$1.11M.
  • PALATIN TECHNOLOGIES, INC. increase (decrease) in other current liabilities for fiscal 2025 was $141.40K.
  • PALATIN TECHNOLOGIES, INC. increase (decrease) in other current liabilities for fiscal 2024 was -$3.46M.
  • PALATIN TECHNOLOGIES, INC. increase (decrease) in other current liabilities for fiscal 2023 was -$2.04M.
Period endIncrease (Decrease) in Other Current Liabilities 3 monthIncrease (Decrease) in Other Current Liabilities 6 monthIncrease (Decrease) in Other Current Liabilities 9 monthIncrease (Decrease) in Other Current Liabilities 12 month
2025-06-30$141.40K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23
$141.40K
derived: sum of 2 quarters · filed 2025-09-23
$141.40K
10-K · filed 2025-09-23
2025-03-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14
$0.00
10-Q · filed 2025-05-14
2024-12-31$0.00
10-Q · filed 2025-02-13
2024-06-30-$1.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23
-$2.45M
derived: sum of 2 quarters · filed 2025-09-23
-$3.46M
10-K · filed 2025-09-23
2024-03-31-$1.11M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14
-$2.12M
10-Q · filed 2025-05-14
2023-12-31-$1.01M
10-Q · filed 2025-02-13
2023-06-30-$1.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30
-$2.04M
derived: sum of 2 quarters · filed 2024-09-30
-$2.04M
10-K · filed 2024-09-30
2023-03-31-$1.01M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15
-$1.01M
10-Q · filed 2024-05-15
2022-12-31$0.00
10-Q · filed 2024-02-14
2021-03-31-$492.97K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-14
-$7.58M
10-Q · filed 2021-05-14
2020-12-31-$7.09M
10-Q · filed 2021-02-16
2020-03-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-14
$0.00
10-Q · filed 2021-05-14
2019-12-31$0.00
10-Q · filed 2021-02-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lipocine Inc. (LPCN)United States$0.017B-1.79
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
Rocket One Inc. (RKTO)United States$0.019B
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B